{"id":2885,"date":"2025-08-06T15:36:46","date_gmt":"2025-08-06T06:36:46","guid":{"rendered":"https:\/\/atlas.ncc.go.jp\/?page_id=2885"},"modified":"2026-02-19T10:06:40","modified_gmt":"2026-02-19T01:06:40","slug":"ATLAS-Board","status":"publish","type":"page","link":"https:\/\/atlas.ncc.go.jp\/en\/governance\/ATLAS-Board\/","title":{"rendered":"ATLAS Board"},"content":{"rendered":"

One of the major goals of the ATLAS project is to expand into an international clinical trial group based on the network with Asian countries established through the ATLAS project. There are large-scale international clinical trial groups in Europe and the United States, and each group has excellent systems in place to efficiently conduct international collaborative clinical trials. As the first step in establishing such a system as an international clinical trial group, we established the ATLAS Board on March 16, 2023, consisting of representatives from Asian countries.<\/p>\r\n

The Board has the authority to discuss and approve the future direction, strategy, and activities of ATLAS. Board meetings are held four times a year, where participating members discuss a variety of topics from diverse perspectives and are responsible for developing ATLAS as a sustainable international clinical trial group.<\/p>\r\n

The ATLAS Board consists of the following members. Members are chosen from institutions that participate in ATLAS clinical research and enrolling patients.<\/p>\r\n

ATLAS Policy<\/h2>\r\n

ATLAS Bylaws version 1.0<\/a><\/p>\r\n

ATLAS BOARD MEMBERS<\/h2>\r\n

(Countries are listed in alphabetical order.)<\/p>\r\n

\"\"<\/a> \"\"<\/a> \"\"<\/a><\/p>\r\n

Japan<\/strong><\/h3>\r\n

\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \"\"<\/a> \"\"<\/a><\/p>\r\n

Malaysia<\/strong><\/h3>\r\n

\"\"<\/a> \"\"<\/a> \"\"<\/a>
\r\n
\r\n<\/strong><\/p>\r\n

Philippine<\/strong><\/h3>\r\n

\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \"\"<\/a> \"\"<\/a><\/p>\r\n

Singapore<\/strong><\/h3>\r\n

\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \"\" \"\"<\/a><\/p>\r\n

South Korea<\/strong><\/h3>\r\n

\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u3000\u3000\u3000\u00a0\"\"<\/a><\/p>\r\n

Taiwan<\/strong><\/h3>\r\n

\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \"\"<\/a> \"\"<\/a><\/p>\r\n

Thailand<\/strong><\/h3>\r\n

\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \"\"<\/a> \"\"<\/a><\/p>\r\n

Vietnam<\/strong><\/h3>\r\n

\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\"\"<\/a> \"\"<\/a><\/p>\r\n

Top 5 site in 2025<\/h3>\r\n

Elected members<\/h3>\r\n

\"\"<\/a> \"\"<\/a> \"\"<\/a><\/p>","protected":false},"excerpt":{"rendered":"One of the major goals of the ATLAS project is to expand into an international clinical trial group based on the network with Asian countries established through the ATLAS project. There are large-scale international clinical trial groups in Europe and the United States, and each group has excellent systems in place to efficiently conduct international […]","protected":false},"author":23,"featured_media":0,"parent":3707,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_locale":"en_US","_original_post":"https:\/\/atlas.ncc.go.jp\/atlasprj_cms\/?page_id=2586","footnotes":""},"class_list":["post-2885","page","type-page","status-publish","hentry","en-US"],"acf":{"page_preface":"The ATLAS project aims to establish an international clinical trial group, leveraging a network of Asian countries. Established on March 16, 2023, the ATLAS Board consists of representatives from numerous Asian countries and the project's direction, strategy, and activities. Meeting quarterly, the Board ensures the long-term development of ATLAS through diverse and comprehensive discussions. Members are chosen from institutes involved in ATLAS clinical research and patient enrollment."},"_links":{"self":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages\/2885","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/comments?post=2885"}],"version-history":[{"count":9,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages\/2885\/revisions"}],"predecessor-version":[{"id":3934,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages\/2885\/revisions\/3934"}],"up":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/pages\/3707"}],"wp:attachment":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/media?parent=2885"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}